History and molecular characteristics of a patient with terminal deletion of 14q. Is this another syndrome with a striking phenotype?
Aleksandra Jezela‐Stanek, Małgorzata Krajewska‐Walasek(Children's Memorial Health Institute), Elżbieta Ciara(Children's Memorial Health Institute), Krystyńa Chrzańowska(University Medical Center Groningen), Marzena Kucharczyk(Children's Memorial Health Institute), Magdalena Pelc(Children's Memorial Health Institute), Anna Gutkowska(Children's Memorial Health Institute)
Cited by 6
Related Papers
Clinical and molecular diagnosis, screening and management of Beckwith–Wiedemann syndrome: an international consensus statement
|Nature Reviews Endocrinology|2018|596
Autosomal-Recessive Mutations in SLC34A1 Encoding Sodium-Phosphate Cotransporter 2A Cause Idiopathic Infantile Hypercalcemia
|Journal of the American Society of Nephrology|2015|284
Heterozygous missense mutations in SMARCA2 cause Nicolaides-Baraitser syndrome
|Nature Genetics|2012|244
New perspective in diagnostics of mitochondrial disorders: two years’ experience with whole-exome sequencing at a national paediatric centre
|Journal of Translational Medicine|2016|233